Sigma Healthcare stock rises 1.15 percent as Macquarie stays bullish
Published on 10/07/2026 at 03:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sigma Healthcare (ISIN AU000000SIG5) was trading at AUD 2.65 on the ASX on October 7, 2026 at 12:13 p.m. AEDT, up 1.15 percent from the prior close of AUD 2.62. The move comes as analysts continue to frame the pharmacy distributor around earnings growth and integration execution.
Macquarie keeps a Buy rating
According to Markets Insider on October 5, 2026, Macquarie maintained its Buy rating on Sigma Healthcare and set a AUD 3.20 price target. The same report said Morgan Stanley maintained a Buy rating with a AUD 3.30 target on September 21, 2026.
The targets place analyst attention above the October 7 market price, but the valuation case depends on Sigma converting its enlarged distribution platform into durable profit growth. That makes margin development and cash generation more important than revenue scale alone.
Fiscal 2026 revenue reaches AUD 10.8 billion
Simply Wall St reports that Sigma Healthcare's fiscal 2026 revenue reached AUD 10.8 billion, up 81 percent from fiscal 2025. Net income rose 34 percent to AUD 709.2 million, while the profit margin fell to 6.5 percent from 8.8 percent as expenses increased.
Adjusted EPS also improved to AUD 0.062 from AUD 0.051 in fiscal 2025. The combination is important: Sigma expanded sales sharply, yet the lower margin shows that integration costs and operating expenses remain central to the earnings story.
Consensus target stands at AUD 3.198
MarketScreener lists a Buy consensus from 16 analysts and an average target price of AUD 3.198. Its September 15, 2026 company update also said Sigma's Auckland distribution center had begun deliveries, with 78 customers supported at launch.
The market is therefore weighing two different numbers. Revenue of AUD 10.8 billion demonstrates the scale created by the Chemist Warehouse relationship, while the 6.5 percent margin shows why execution remains a decisive test for the investment case.
Sigma Healthcare stock trades at AUD 2.65
Sigma Healthcare stock was trading at AUD 2.65 on the ASX on October 7, 2026 at 12:13 p.m. AEDT, with a 52-week range of AUD 2.47 to AUD 3.20 and volume of 3,302,939 shares. Its market capitalization was AUD 30.6 billion.
Sigma Healthcare stock facts
- Company: Sigma Healthcare Limited
- ISIN: AU000000SIG5
- Ticker: SIG.AX
- Trading venue: ASX
- Price (as of October 7, 2026, 12:13 p.m. AEDT): AUD 2.65
- Market capitalization: AUD 30.6 billion (as of October 7, 2026)
- 52-week range: AUD 2.47-3.20 (as of October 7, 2026)
- Sector / Industry: Healthcare / Medical - Distribution
